NexGard 136 mg Chewable Tablets for Dogs >25-50 kg

Dosage:
The veterinary medicinal product should be administered at a dose of 2.7 to 7 mg/kg
bodyweight of afoxolaner in accordance with the following table:
Strength and number of chewable tablets to be administeredBodyweight
of dog (kg)
NexGard
11 mg
NexGard
28 mg
NexGard
68 mg
NexGard
136 mg
2–41> 4–101> 10–251> 25–501
For dogs above 50 kg bodyweight, use an appropriate combination of chewable
tablets of different/same strengths.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
The chewable tablets should not be divided. Underdosing could result in ineffective
use and may favour resistance development.
Method of administration:
The tablets are chewable and palatable to most dogs. If the dog does not accept the
tablets directly they may be administered with food.
Treatment schedule:
Treatment of flea and tick infestations:
Monthly intervals throughout the flea and/or tick seasons, based on local
epidemiological situations and the animal’s lifestyle.
Treatment of demodicosis (caused by Demodex canis):
Administration of the veterinary medicinal product leads to a marked improvement of
clinical signs. Treatment should be continued until two negative skin scrapings are
obtained one month apart. Severe cases may require prolonged monthly treatments.
As demodicosis is a multi-factorial disease, where possible, it is advisable to also
treat any underlying disease appropriately.
Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis):

Amended pages: January 2026
Monthly administration of the veterinary medicinal product for two consecutive
months. Further monthly administration may be required based on clinical
assessment and skin scrapings.
Treatment of ear mite infestations Otodectes cynotis):
A single dose of the veterinary medicinal product should be administered. A further
veterinary examination one month after the initial treatment is recommended as
some animals may require a second treatment.